Insulin/NFκB protects against ischemia-induced necrotic cardiomyocyte death

Biochemical and Biophysical Research Communications

Volumn 467, Issue 2, 2015, Pages 451-457

  Díaz, Ariel ^a   Humeres, Claudio ^a   González, Verónica ^a   Gómez, María Teresa ^a   Montt, Natalia ^a   Sanchez, Gina ^a   Chiong, Mario ^a   García, Lorena ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Cell death; Cell signaling; Heart; Insulin; Ischemia

Indexed keywords

CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LACTATE DEHYDROGENASE; PROTEIN KINASE B; CARDIOTONIC AGENT;

ANIMAL CELL; ARTICLE; CELL DEATH; COMPARATIVE STUDY; DNA FRAGMENTATION; DRUG EFFECT; ENZYME INHIBITION; EX VIVO STUDY; FLOW CYTOMETRY; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; IN VITRO STUDY; INSULIN TREATMENT; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; ANIMAL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HEART; METABOLISM; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; NECROSIS; ORGAN CULTURE TECHNIQUE; PATHOLOGY; PATHOPHYSIOLOGY; PRIMARY CELL CULTURE; SECRETION (PROCESS); SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; CARDIOTONIC AGENTS; DNA FRAGMENTATION; GENE EXPRESSION; HEART; INSULIN; L-LACTATE DEHYDROGENASE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; NECROSIS; NF-KAPPA B; ORGAN CULTURE TECHNIQUES; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 84944393460     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2015.09.171     Document Type: Article

References (45)

1. M. Chiong, Z.V. Wang, Z. Pedrozo, D.J. Cao, R. Troncoso, M. Ibacache, A. Criollo, A. Nemchenko, J.A. Hill, and S. Lavandero Cardiomyocyte death: mechanisms and translational implications Cell Death Dis. 2 2011 e244
2. J.D. Schipke, R. Friebe, and E. Gams Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials Eur. J. Cardiothorac. Surg. 29 2006 479 485
3. T. Doenst, W. Bothe, and F. Beyersdorf Therapy with insulin in cardiac surgery: controversies and possible solutions Ann. Thorac. Surg. 75 2003 S721 S728
4. F. Fath-Ordoubadi, and K.J. Beatt Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials Circulation 96 1997 1152 1156
5. J.F. LaDisa Jr., J.G. Krolikowski, P.S. Pagel, D.C. Warltier, and J.R. Kersten Cardioprotection by glucose-insulin-potassium: dependence on KATP channel opening and blood glucose concentration before ischemia Am. J. Physiol. Heart Circ. Physiol. 287 2004 H601 H607
6. C.S. Apstein Glucose-insulin-potassium for acute myocardial infarction: remarkable results from a new prospective, randomized trial Circulation 98 1998 2223 2226
7. A.K. Jonassen, E. Aasum, R.A. Riemersma, O.D. Mjos, and T.S. Larsen Glucose-insulin-potassium reduces infarct size when administered during reperfusion Cardiovasc Drugs Ther. 14 2000 615 623
8. L. Bertrand, S. Horman, C. Beauloye, and J.L. Vanoverschelde Insulin signalling in the heart Cardiovasc Res. 79 2008 238 248
9. S.R. Mehta, S. Yusuf, R. Diaz, J. Zhu, P. Pais, D. Xavier, E. Paolasso, R. Ahmed, C. Xie, K. Kazmi, J. Tai, A. Orlandini, J. Pogue, L. Liu, and C.-E.T.G. Investigators Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial JAMA 293 2005 437 446
10. A. Misra, S.B. Haudek, P. Knuefermann, J.G. Vallejo, Z.J. Chen, L.H. Michael, N. Sivasubramanian, E.N. Olson, M.L. Entman, and D.L. Mann Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction Circulation 108 2003 3075 3078
11. J.W. Gordon, J.A. Shaw, and L.A. Kirshenbaum Multiple facets of NF-kappaB in the heart: to be or not to NF-kappaB Circ. Res. 108 2011 1122 1132
12. R. Foncea, M. Andersson, A. Ketterman, V. Blakesley, M. Sapag-Hagar, P.H. Sugden, D. LeRoith, and S. Lavandero Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes J. Biol. Chem. 272 1997 19115 19124
13. M. Ibacache, G. Sanchez, Z. Pedrozo, F. Galvez, C. Humeres, G. Echevarria, J. Duaso, M. Hassi, L. Garcia, G. Diaz-Araya, and S. Lavandero Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart Biochim. Biophys. Acta 1822 2012 537 545
14. Z. Pedrozo, G. Sanchez, N. Torrealba, R. Valenzuela, C. Fernandez, C. Hidalgo, S. Lavandero, and P. Donoso Calpains and proteasomes mediate degradation of ryanodine receptors in a model of cardiac ischemic reperfusion Biochim. Biophys. Acta 1802 2010 356 362
15. V.W. Wong, M. Mardini, N.W. Cheung, and A.S. Mihailidou High-dose insulin in experimental myocardial infarction in rabbits: protection against effects of hyperglycaemia J. Diabetes Complicat. 25 2011 122 128
16. W. Xing, W. Yan, F. Fu, Y. Jin, L. Ji, W. Liu, L. Wang, A. Lv, Y. Duan, J. Zhang, H. Zhang, and F. Gao Insulin inhibits myocardial ischemia-induced apoptosis and alleviates chronic adverse changes in post-ischemic cardiac structure and function Apoptosis 14 2009 1050 1060
17. H.X. Zhang, Y.M. Zang, J.H. Huo, S.J. Liang, H.F. Zhang, Y.M. Wang, Q. Fan, W.Y. Guo, H.C. Wang, and F. Gao Physiologically tolerable insulin reduces myocardial injury and improves cardiac functional recovery in myocardial ischemic/reperfused dogs J. Cardiovasc Pharmacol. 48 2006 306 313
18. F. Gao, E. Gao, T.L. Yue, E.H. Ohlstein, B.L. Lopez, T.A. Christopher, and X.L. Ma Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation Circulation 105 2002 1497 1502
19. C.P. Baines, L. Wang, M.V. Cohen, and J.M. Downey Myocardial protection by insulin is dependent on phospatidylinositol 3-kinase but not protein kinase C or KATP channels in the isolated rabbit heart Basic Res. Cardiol. 94 1999 188 198
20. P.R. Maroko, P. Libby, B.E. Sobel, C.M. Bloor, H.D. Sybers, W.E. Shell, J.W. Covell, and E. Braunwald Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion Circulation 45 1972 1160 1175
21. C.S. Apstein The benefits of glucose-insulin-potassium for acute myocardial infarction (and some concerns) J. Am. Coll. Cardiol. 42 2003 792 795
22. D.J. Hausenloy, and D.M. Yellon Reperfusion injury salvage kinase signalling: taking a risk for cardioprotection Heart Fail Rev. 12 2007 217 234
23. J. Downward How BAD phosphorylation is good for survival Nat. Cell Biol. 1 1999 E33 E35
24. J. Zha, H. Harada, E. Yang, J. Jockel, and S.J. Korsmeyer Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L) Cell 87 1996 619 628
25. S. Shimizu, Y. Eguchi, W. Kamiike, S. Waguri, Y. Uchiyama, H. Matsuda, and Y. Tsujimoto Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: possible involvement of common mediators in apoptotic and necrotic signal transductions Oncogene 12 1996 2045 2050
26. Y. Tsujimoto, S. Shimizu, Y. Eguchi, W. Kamiike, and H. Matsuda Bcl-2 and Bcl-xL block apoptosis as well as necrosis: possible involvement of common mediators in apoptotic and necrotic signal transduction pathways Leukemia 11 Suppl 3 1997 380 382
27. I. Marzo, C. Brenner, N. Zamzami, S.A. Susin, G. Beutner, D. Brdiczka, R. Remy, Z.H. Xie, J.C. Reed, and G. Kroemer The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins J. Exp. Med. 187 1998 1261 1271
28. I. Marzo, C. Brenner, N. Zamzami, J.M. Jurgensmeier, S.A. Susin, H.L. Vieira, M.C. Prevost, Z. Xie, S. Matsuyama, J.C. Reed, and G. Kroemer Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis Science 281 1998 2027 2031
29. S. Shimizu, Y. Eguchi, W. Kamiike, Y. Funahashi, A. Mignon, V. Lacronique, H. Matsuda, and Y. Tsujimoto Bcl-2 prevents apoptotic mitochondrial dysfunction by regulating proton flux Proc. Natl. Acad. Sci. U. S. A. 95 1998 1455 1459
30. H.C. Dan, M.J. Cooper, P.C. Cogswell, J.A. Duncan, J.P. Ting, and A.S. Baldwin Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and raptor in association with IKK Genes Dev. 22 2008 1490 1500
31. V. Parra, H.E. Verdejo, M. Iglewski, A. Del Campo, R. Troncoso, D. Jones, Y. Zhu, J. Kuzmicic, C. Pennanen, C. Lopez-Crisosto, F. Jana, J. Ferreira, E. Noguera, M. Chiong, D.A. Bernlohr, A. Klip, J.A. Hill, B.A. Rothermel, E.D. Abel, A. Zorzano, and S. Lavandero Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the Akt-mTOR-NFkB-Opa-1 signaling pathway Diabetes 63 2014 75 88
32. K. Van der Heiden, S. Cuhlmann, A. Luong le, M. Zakkar, and P.C. Evans Role of nuclear factor kappaB in cardiovascular health and disease Clin. Sci. (Lond) 118 2010 593 605
33. R. Morishita, T. Sugimoto, M. Aoki, I. Kida, N. Tomita, A. Moriguchi, K. Maeda, Y. Sawa, Y. Kaneda, J. Higaki, and T. Ogihara In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction Nat. Med. 3 1997 894 899
34. B. Zingarelli, P.W. Hake, A. Denenberg, and H.R. Wong Sesquiterpene lactone parthenolide, an inhibitor of IkappaB kinase complex and nuclear factor-kappaB, exerts beneficial effects in myocardial reperfusion injury Shock 17 2002 127 134
35. C.A. Latanich, and L.H. Toledo-Pereyra Searching for NF-kappaB-based treatments of ischemia reperfusion injury J. Invest Surg. 22 2009 301 315
36. S. Frantz, K. Hu, B. Bayer, S. Gerondakis, J. Strotmann, A. Adamek, G. Ertl, and J. Bauersachs Absence of NF-kappaB subunit p50 improves heart failure after myocardial infarction FASEB J. 20 2006 1918 1920
37. Y. Fan, J. Dutta, N. Gupta, G. Fan, and C. Gelinas Regulation of programmed cell death by NF-kappaB and its role in tumorigenesis and therapy Adv. Exp. Med. Biol. 615 2008 223 250
38. S. Papa, C. Bubici, F. Zazzeroni, C.G. Pham, C. Kuntzen, J.R. Knabb, K. Dean, and G. Franzoso The NF-kappaB-mediated control of the JNK cascade in the antagonism of programmed cell death in health and disease Cell Death Differ. 13 2006 712 729
39. N. Liu, S.M. Raja, F. Zazzeroni, S.S. Metkar, R. Shah, M. Zhang, Y. Wang, D. Bromme, W.A. Russin, J.C. Lee, M.E. Peter, C.J. Froelich, G. Franzoso, and P.G. Ashton-Rickardt NF-kappaB protects from the lysosomal pathway of cell death EMBO J. 22 2003 5313 5322
40. H. Reichenspurner, C. Russ, F. Wagner, P. Uberfuhr, G. Nollert, C. Weinhold, and B. Reichart Comparison of UW versus HTK solution for myocardial protection in heart transplantation Transpl. Int. 7 Suppl 1 1994 S481 S484
41. V. Jeevanandam, M.L. Barr, J.S. Auteri, J.A. Sanchez, J. Fong, F.A. Schenkel, C.C. Marboe, R.E. Michler, C.R. Smith, and E.A. Rose University of Wisconsin solution versus crystalloid cardioplegia for human donor heart preservation. A randomized blinded prospective clinical trial J. Thorac. Cardiovasc Surg. 103 1992 194 198 discussion 198-199
42. S. Demertzis, J. Wippermann, J. Schaper, T. Wahlers, H.J. Schafers, I. Wagenbreth, B. Hausen, and A. Haverich University of Wisconsin versus St. Thomas' Hospital solution for human donor heart preservation Ann. Thorac. Surg. 55 1993 1131 1137
43. K. Sakata, Y. Kawashima, H. Ichikawa, T. Oya, T. Takahashi, A. Otaki, S. Ishikawa, and Y. Morishita University of Wisconsin solution versus modified collins solution for canine heart preservation: an experimental study Int. J. Angiol. 6 1997 176 179
44. S.F. Chien, J.N. Diana, P.R. Oeltgen, and R. Salley Functional studies of the heart during a 24-hour preservation using a new autoperfusion preparation J. Heart Lung Transpl. 10 1991 401 408
45. X.L. Li, K. Man, Y.F. Liu, T.K. Lee, S.H. Tsui, C.K. Lau, C.M. Lo, and S.T. Fan Insulin in University of Wisconsin solution exacerbates the ischemic injury and decreases the graft survival rate in rat liver transplantation Transplantation 76 2003 44 49